Anebulo Pharmaceuticals (ANEB) Change in Cash (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly Change in Cash of -$1.3 million for Q4 2025, down 109.66% year-over-year from $13.6 million in Q4 2024, and down 3.15% quarter-over-quarter from -$1.3 million in Q3 2025.
Anebulo Pharmaceuticals (ANEB) Change in Cash (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Change in Cash for 6 consecutive years, with -$1.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash fell 109.66% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at -$6.0 million (down 171.31% YoY), while the FY2025 annual figure was $8.5 million, up 204.67% from the prior year.
- Change in Cash fell to -$1.3 million in Q4 2025 per ANEB's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $16.7 million in Q2 2021 and bottomed at -$2.9 million in Q2 2023.
- Historically, Change in Cash has averaged $328078.4 across 5 years, with a median of -$1.6 million in 2024.
- Annual changes were most pronounced in 2021 — Change in Cash plunged 476.41% — and 2024, when it soared 824.62%.
- Anebulo Pharmaceuticals' Change in Cash stood at -$1.2 million in 2021, then slumped by 138.44% to -$2.9 million in 2022, then surged by 34.37% to -$1.9 million in 2023, then jumped by 824.62% to $13.6 million in 2024, then tumbled by 109.66% to -$1.3 million in 2025.
- Business Quant data shows ANEB's Change in Cash at -$1.3 million in Q4 2025, -$1.3 million in Q3 2025, and -$1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.72 Mn |
| Dec 31, 2024 | 13.59 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | -2.05 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -2.19 Mn |
| Dec 31, 2022 | -2.86 Mn |
| Sep 30, 2022 | 4.67 Mn |
| Jun 30, 2022 | -2.00 Mn |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | -1.20 Mn |
| Sep 30, 2021 | -777,902.00 |
| Jun 30, 2021 | 16.68 Mn |
| Mar 31, 2021 | 827,080.00 |